Navigation Links
Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program
Date:1/17/2012

LA JOLLA, Calif., Jan. 17, 2012 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company commercializing and developing genomic-driven solutions to solve a wide range of global challenges, today announced they have hired George E. Stagnitti as Vice President for Nutritional Products. Stagnitti is a proven leader with experience in developing sophisticated research programs and translating these into high value food and nutritional products for humans and animals. At SGI he will be responsible for leading and directing all aspects of the company's product and commercial development efforts in the food and nutritional products program.

"We formed SGI with the belief that our powerful and proprietary technologies could be leveraged to develop products in a variety of industries," said J. Craig Venter, Ph.D., SGI CEO and founder. "SGI is poised to lead the way in creating unique food products and new systems for sustainably producing nutritional ingredients to help feed a growing world population. We have made progress in our internal food research and development program over the last 12 to 24 months and are eager now to tap into George's vast experience and expertise to take this program to the next level," said Dr. Venter.

Stagnitti is an innovative leader in the food industry. Most recently he has been an advisor to Efficas Medical Foods and Nutrition, LLC and Stolle Milk Biologics, Inc. where he led day to day strategic research and development for a variety of human, animal and milk protein nutritional products. At both companies he was also a key business development leader providing guidance to negotiate and structure multiple partnerships, acquisition, licensing and financing agreements. Prior to his consulting work Stagnitti was a Vice President at Efficas, Inc.

Since he began his career in 1982, Stagnitti has held positions of increasing responsibility and leadership at some of the largest and most important food ingredient, flavor and nutritional product companies. Highlights include: Director, Food and Beverage Product Development and Applications at OmegaTech, Inc. from 2000 to 2002, and then with Martek Biosciences Corporation from 2002 until 2004 following the acquisition of OmegaTech, Inc. by Martek.; Director of Strategic Business Unit Flavors for North America at Danisco Cultor Ingredients from 1999-2000; Director, CFS Technical Service at Cultor Food Science from 1996 to 1999; Director, Food Applications, Technical Service at Pfizer Inc. Food Science Group from 1991 to 1996.

Stagnitti received a Bachelor's degree in Food Science from University of Maryland, College Park in 1982, and a Master of Arts in Science/Chemistry from Fairleigh Dickinson University in 1990.  

About Synthetic Genomics Inc.

SGI, a privately held company founded in 2005, is dedicated to developing and commercializing genomic-driven solutions to address a wide range of global challenges. The company is focused on several key research and business programs including: developing algae biofuels in alliance with Exxon Mobil Research and Engineering Company, microbial-enhanced hydrocarbon recovery and conversion through an agreement with BP, new and improved food and nutritional products, and clean water technologies. SGI is also involved in synthetically derived vaccine development through Synthetic Genomic Vaccines Inc. (SGVI), a company co-founded with the J. Craig Venter Institute; and to developing sustainable crops and agricultural products through Agradis Inc., a company co-founded with Plenus S.A. de C.V. For more information go to: www.syntheticgenomics.com.

SGI Media Contact:

Heather Kowalski, hkowalski@syntheticgenomics.com; 858-361-0466


'/>"/>
SOURCE Synthetic Genomics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry
2. The MathWorks Sponsors iGEM Competition for Synthetic Biology at MIT : MATLAB and SimBiology Help Accelerate Design of Synthetic Biological Systems
3. RNAi Helps Illuminate the Inner Workings of the Cell Cycle: Synthetic RNAissance™ Genes Created by DNA2.0 Enable Key Research
4. Synthetic Biology Importance in the 21st Century
5. Synthetic Biology: The Next Biotech Revolution Is Brewing
6. Pepscan Achieves a Breakthrough With CLIPS Immunogen Technology: Synthetic Peptide Antigen is Able to Induce Fully Functional Antibodies Against a Formerly Intractable GPCR Target CXCR7
7. Synthetic Biology on the Rise
8. Does Synthetic Biology Need Synthesized Ethics?
9. Synthetic Genomics Inc. and ExxonMobil Research and Engineering Company Sign Exclusive, Multi-Year Agreement to Develop Next Generation Biofuels Using Photosynthetic Algae
10. Swedish-American Life Science Summit (SALSS) to Address Major Issues Including Healthcare Reform, Synthetic Biology and Innovative Financing for Biotechs
11. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... announced the three Winners and six Finalists of the 2017 Blavatnik Regional Awards ... the Blavatnik Family Foundation and administered by the New York Academy of Sciences ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the first-ever genomics analysis platform specifically designed for life science researchers to ... of pioneering researcher Rosalind Franklin, who made a major contribution to the ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., a ... Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. Nicolas ... practices and how Proscia improves lab economics and realizes an increase in diagnostic ...
(Date:10/11/2017)... Bay, Florida (PRWEB) , ... October 11, 2017 ... ... and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel ... (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the cell ...
Breaking Biology Technology:
(Date:4/18/2017)... 2017  Socionext Inc., a global expert in SoC-based imaging and ... the M820, which features the company,s hybrid codec technology. A demonstration ... Probe, Inc., will be showcased during the upcoming Medtec Japan at ... the Las Vegas Convention Center April 24-27. ... Click here for an ...
(Date:4/13/2017)... April 13, 2017 UBM,s Advanced Design and ... will feature emerging and evolving technology through its 3D ... will run alongside the expo portion of the event ... and demonstrations focused on trending topics within 3D printing ... and manufacturing event will take place June 13-15, 2017 at ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
Breaking Biology News(10 mins):